Publicaciones (134) Publicaciones de José Miguel Rodríguez González Moro

2024

  1. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

2023

  1. Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 797-804

  2. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  3. Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach

    Respiratory Medicine, Vol. 207

  4. Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney

    Redox Biology, Vol. 68

  5. Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: A population-based study

    BMJ Open Respiratory Research, Vol. 10, Núm. 1

  6. The Clinical Profile of Patients with COPD Is Conditioned by Age

    Journal of Clinical Medicine, Vol. 12, Núm. 24

  7. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

  8. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017

    Archivos de Bronconeumologia, Vol. 59, Núm. 3, pp. 142-151

2022

  1. Asma bronquial

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 65, pp. 3829-3837

  2. Decalogue for the selection of oral antibiotics for lower respiratory tract infections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 16-29

  3. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study

    Respiratory Research, Vol. 23, Núm. 1

  4. Real-life burden of hospitalisations due to COPD exacerbations in Spain

    ERJ Open Research, Vol. 8, Núm. 3

  5. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients

    International journal of molecular sciences, Vol. 23, Núm. 18

  6. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

    Respiratory Medicine, Vol. 200

  7. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19

    Science Progress, Vol. 105, Núm. 1

2021

  1. Clinical Management of COPD in a Real-World Setting. A Big Data Analysis

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 94-100

  2. Evidencia científica sobre productos de tabaco calentado. Una revisión narrativa

    Revista española de drogodependencias, Núm. 46, pp. 40-57

  3. Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E23-E28

  4. Prevalence and Determinants of COPD in Spain: EPISCAN II

    Archivos de bronconeumologia, Vol. 57, Núm. 1, pp. 61-69